The implications of diagnosis of small for gestational age fetuses using European and South Asian growth charts: an

Gianpaolo Maso1, Mathota A M M Jayawardane2, Salvatore Alberico1

  • 1Department of Obstetrics and Gynecology, Institute for Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy.

Insights

Diagnosing small for gestational age (SGA) using population-specific growth charts is crucial. Inappropriate charts lead to misdiagnosis and unnecessary interventions, impacting perinatal outcomes.

Area of Science:

  • Perinatal Medicine
  • Maternal-Fetal Medicine
  • Neonatology

Background:

  • Small for gestational age (SGA) is linked to increased perinatal morbidity and mortality.
  • Birth weight and fetal size vary significantly across different populations.
  • Accurate antenatal diagnosis of SGA is essential for appropriate management.

Purpose of the Study:

  • To evaluate the impact of using Bangladeshi and European antenatal growth charts for SGA diagnosis in Sri Lankan infants.
  • To compare perinatal outcomes based on SGA classification using different growth references.
  • To determine the clinical significance of SGA diagnosis using population-specific charts.

Main Methods:

  • Retrospective review of estimated fetal weight before delivery.
  • Classification of infants into three groups based on SGA diagnosis using Bangladeshi and European growth charts.
  • Comparison of adverse perinatal outcomes across the identified groups.

Main Results:

  • Prevalence of SGA differed significantly: 12.7% (Bangladeshi chart) vs. 51.7% (European chart).
  • Infants classified as SGA by the Bangladeshi chart (Group 1) showed significantly higher rates of emergency cesarean section, fetal distress, and intrauterine death.
  • No significant outcome differences were observed between infants classified as SGA by European charts only (Group 2) and those not SGA by either chart (Group 3).

Conclusions:

  • Only SGA diagnosed using population-based growth charts identifies infants at risk for adverse outcomes.
  • The use of non-population-specific growth charts can lead to misdiagnosis of SGA.
  • Inappropriate growth chart selection may result in unnecessary medical interventions and management.